Novartis Investigative Site

Port Elizabeth, Eastern Cape 6001

0 studies enrolling now · 2 studies all time

What they study most

Non Alcoholic Steatohepatitis (NASH), Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. — Stopped early